⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 2, 2024Open Access

Figure S1 from Mass Spectrometry–Based Proteomics Identifies Serpin B9 as a Key Protein in Promoting Bone Metastases in Lung Cancer

Yufeng Huang Ming Gong Hongmin Chen Chuangzhong Deng Xiaojun Zhu Jiaming Lin Anfei Huang Yanyang Xu Yi Tai Guohui Song Huaiyuan Xu Jinxin Hu Huixiong Feng Qinglian Tang Jinchang Lu Jin Wang

View Full Paper

Ask AI

Bookmark

Share

Abstract

Highly bone-metastatic LLC1-BM3 cells were established using a bone metastatic mouse model by CA injection. A-D: Representative BLI images of differnt organic metastases.(n=10); A: lung metastases; B: bone metastases of lower limb; C: bone metastases of spine; D: brain metastases.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Huang et al. (2024) studied this question.

synapsesocial.com/papers/68e70c5ab6db64358768602f https://doi.org/10.1158/1541-7786.25523225

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S7 from Mass Spectrometry–Based Proteomics Identifies Serpin B9 as a Key Protein in Promoting Bone Metastases in Lung Cancer2024
2Figure S3 from Mass Spectrometry–Based Proteomics Identifies Serpin B9 as a Key Protein in Promoting Bone Metastases in Lung Cancer2024
3Data from Mass Spectrometry–Based Proteomics Identifies Serpin B9 as a Key Protein in Promoting Bone Metastases in Lung Cancer2024
4Figure S2 from Mass Spectrometry–Based Proteomics Identifies Serpin B9 as a Key Protein in Promoting Bone Metastases in Lung Cancer2024
5Figure S6 from Mass Spectrometry–Based Proteomics Identifies Serpin B9 as a Key Protein in Promoting Bone Metastases in Lung Cancer2024